Macias v. Novo Nordisk A/S et al
Tennessee Middle District Court | |
Judge: | Eli J Richardson |
Referred: | Alistair Newbern |
Case #: | 3:24-cv-00842 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity-Product Liability |
Case Filed: | Jul 11, 2024 |
Terminated: | Aug 16, 2024 |
Last checked: Sunday Aug 25, 2024 4:40 AM CDT |
Defendant
Novo Nordisk A/S
|
|
Defendant
Novo Nordisk Inc.
|
|
Defendant
Novo Nordisk North America Operations A/S
|
|
Defendant
Novo Nordisk Pharmaceutical Industries LP
|
|
Defendant
Novo Nordisk Research Center Seattle, Inc.
|
|
Defendant
Novo Nordisk US Commercial Holdings, Inc.
|
|
Defendant
Novo Nordisk US Holdings, Inc.
|
|
Plaintiff
Dana Macias
|
Represented By
|
Docket last updated: 09/30/2024 11:59 PM CDT |
Friday, August 16, 2024 | ||
utility
Terminate Civil Case
Fri 08/16 8:39 AM
***Civil Case Terminated per Text Order 7 . (kc) |
||
misc
Annotation - Docket
Fri 08/16 8:45 AM
This case has been transferred to the United States District Court for the Eastern District of Pennsylvania. (kc) |
||
misc
Annotation - Docket
Fri 08/16 1:10 PM
Case transferred from Tennessee Middle has been opened in Eastern District of Pennsylvania as case 2:24-cv-04269, filed 08/16/2024. (kc) |
||
Wednesday, August 14, 2024 | ||
7 | 7
order
Order
Wed 08/14 11:15 AM
TEXT ORDER: Pursuant to the Conditional Transfer Order (CTO-20) of the Judicial Panel on Multidistrict Litigation, Docket No. 3094, this case is hereby transferred to the United States District Court for the Eastern District of Pennsylvania for coordinated or consolidated proceedings. The Clerk of Court is directed to close this case and electronically transmit the record to the United States District Court for the Eastern District of Pennsylvania. Signed by District Judge Eli J. Richardson on 08/14/2024. (lh) |
|
Thursday, August 08, 2024 | ||
6 | 6
notice
Notice (Other)
Thu 08/08 6:45 AM
CERTIFIED CONDITIONAL TRANSFER (CTO-20) ORDER IN RE GLUCAGONLIKE PEPTIDE1 RECEPTOR AGONISTS (GLP1 RAS) PRODUCTS LIABILITY LITIGATION, MDL 3094 received from Eastern District of Pennsylvania. (Case ready for closing/transfer) (hb) |
|
Thursday, July 11, 2024 | ||
5 | 5
notice
Notice of Case Management Conference
Thu 07/11 3:28 PM
NOTICE of Initial Case Management Conference by Telephone is set for 9/5/2024 at 09:30 AM before Magistrate Judge Alistair Newbern. (kc) |
|
4 | 4
notice
Notice/Information re Consent of the Parties to MJ
Thu 07/11 3:24 PM
NOTICE/INFORMATION regarding Consent of the Parties to the Magistrate Judge. (kc) |
|
3 | 3
notice
Notice of Business Entity Disclosure Statement Filing Requirement
Thu 07/11 3:23 PM
NOTICE of Business Entity Disclosure Statement filing requirement. (kc) |
|
2 | 2
notice
Notice of Admin Order 217
Thu 07/11 3:23 PM
NOTICE OF ADMINISTRATIVE ORDER NO. 217 to parties re obligation of counsel to keep Court apprised of current contact information. (kc) |
|
1 | 1
54
pgs
cmp
Complaint
Thu 07/11 3:11 PM
COMPLAINT against Novo Nordisk A/S, Novo Nordisk Inc., Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk US Holdings, Inc. (Filing fee $405, Receipt number ATNMDC-4117895), filed by Dana Macias.(kc) |
|
Att: 1 Attachment - Civil Cover Sheet | ||
misc
Annotation - Bar Status
Thu 07/11 3:25 PM
TN State Bar status verified as active for Carolyn Delyliah Dale admitted to this court . (kc) |
||
misc
Annotation - Bar Status
Thu 07/11 3:25 PM
NY State Bar status verified as active for Paul J. Pennock, Jonathan M. Sedgh not admitted to this court - Local counsel secured . (kc) |
||
misc
Annotation - PHV
Thu 07/11 3:26 PM
NOTICE TO COUNSEL Paul J. Pennock, Jonathan M. Sedgh: WITHIN 21 DAYS, counsel shall file a Motion to Appear Pro Hac Vice, a Certificate of Good Standing signed by the Clerk of a United States District Court or a U. S. appellate court where admitted, and pay a fee of $150.00 (LR 83.01(b)). PHV due by 8/1/2024. (kc) |